Promising new target for treatment of psoriasis is safe, study shows

October 11, 2017, NIHR Biomedical Research Centre at Guy's and St Thomas' and King's College London
Credit: CC0 Public Domain

A protein known to play a significant role in the development of psoriasis can be prevented from functioning without posing a risk to patients, scientists at King's College London have found.

The study, which was supported by the National Institute for Health Research Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, confirmed that a group of inflammatory proteins called 'IL-36' play a significant role in the development of psoriasis and can, in theory, be blocked without posing a risk to .

Psoriasis, which causes red, flaky, crusty patches of skin covered with silvery scales, affects more than 1.8 million in the UK alone. The findings of this study, although still at an early stage, open up the possibility for the development of new drugs to tackle this often debilitating condition.

Dr. Francesca Capon, who led the study at King's College London said: "There was already some evidence to suggest that IL-36 played a significant role in psoriasis. Having confirmed this was the case, the question for us was whether we could block this molecule without posing a risk to patients."

To tackle this problem, Dr. Capon and her team contacted the Born in Bradford (BiB) project, a large study led by Prof John Wright at Bradford Royal Infirmary which is tracking the health of over 13,500 local children and their parents.

"We know that genetic mutations are more common in communities where parental relatedness is widespread and we found 12 women in the BiB cohort who carried a defect that naturally blocked IL-36," said Dr. Capon. "After a series of tests carried out by Dr Satveer Mahil at St John's Institute of Dermatology, we determined that the lack of IL-36 activation had not had an adverse effect on their health which suggests it would be safe to block this molecule in patients with psoriasis."

Medical technology which would enable the blocking of IL-36 group of in patients with psoriasis is already widely available.

Helen McAteer, Chief Executive of the Psoriasis Association, which part-funded the study, said: "Research into psoriasis is enabling us to not only understand the condition better, but the treatments better".

"Current research is having a positive impact on clinical effectiveness, better understanding is providing better treatment outcomes, ultimately improving the lives of those affected by psoriasis."

The paper "An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a therapeutic target", was published today (11 October) in the journal Science Translational Medicine.

Explore further: Psoriasis and psychiatric illnesses—what are the links?

More information: S.K. Mahil el al., "An analysis of IL-36 signature genes and individuals with IL1RL2 knockout mutations validates IL-36 as a psoriasis therapeutic target," Science Translational Medicine (2017). stm.sciencemag.org/lookup/doi/ … scitranslmed.aan2514

Related Stories

Psoriasis and psychiatric illnesses—what are the links?

August 11, 2017
A new review examines the potential link between psoriasis and mental health conditions.

Psoriasis may up risk of melanoma, hematologic cancer

March 28, 2017
(HealthDay)—Patients with psoriasis may have a higher risk of melanoma and hematologic cancers than the general population, according to a study published in the April issue of the Journal of the American Academy of Dermatology.

Severe psoriasis predominantly affects men

March 24, 2017
The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men. A unique study with 5,438 Swedish ...

Severity of psoriasis linked to increased risk of death

August 29, 2017
The more the surface area of the body is covered by psoriasis, the greater the risk of death for the patient suffering from the condition, according to a new analysis by researchers in the Perelman School of Medicine at the ...

Exploring high cholesterol's link with psoriasis

June 12, 2017
A new Northwestern Medicine study published in the Journal of Clinical Investigation has demonstrated how a specific class of immune cells represent a previously unknown link between high cholesterol and the development of ...

Psoriasis impacts QoL for parents of affected children

January 23, 2017
(HealthDay)—Childhood psoriasis impacts parents' quality of life in multiple domains, especially their emotional well-being, according to a study published in the February issue of the Journal of the American Academy of ...

Recommended for you

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.